Clinical Trial

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KL0011034 Injection in Healthy Volunteers

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
To evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single intravenous doses of KL0011034 injection in healthy volunteers.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-28
Trial Details
NCT Number NCT07474545
Lead Sponsor Hunan Kelun Pharmaceutical Co., Ltd.
Conditions Healthy Volunteers
Enrollment 76 participants
Start Date 2026-03-02
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-27